Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Leukemia × Hydromorphone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1 Classical hematology 1

Conditions

Pain, Intractable 1 Neoplasms 1 Mucositis 1 Leukemia 1 Bone Marrow Failure Disorders 1 Anemia, Aplastic 1

Interventions

RFB4(dsFv)-PE38 recombinant immunotoxin 1 Prednisolone 1 Passive Cutaneous Anaphylaxis 1 Morphine 1 Methylprednisolone 1 Methadone 1 KB004 1 Hydromorphone 1 Cytarabine 1 CYC065 1 Antibodies, Monoclonal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended

Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡